title: Virus-like particles for antigen delivery at mucosal surfaces.
abstract: Virus-like particles are a new type of vaccine platform that presents an attractive alternative to more traditional live-attenuated or inactivated/subunit vaccines. Virus-like particles (VLP) are composed of viral structural proteins that assemble spontaneously in cells, mimicking the live virus without the possibility of replication. They are readily recognized by the immune system, inducing both humoral and cellular immune responses. Here we review the development of VLP as vaccine delivery systems at mucosal surfaces. We first summarize the current status of VLP vaccines in general, and then discuss their use in mucosal vaccination approaches for several viruses that enter the host via the urogenital, respiratory or gastrointestinal tract.
authors: Center for Vaccine Research, Department of Microbiology and Molecular Genetics, University of Pittsburgh, PA, USA.
authors: K
authors: K
authors: Schneider-Ohrum
authors: T M
authors: TM
authors: Ross
mesh_terms: D000818:Animals; D000941:Antigens / Q000008:administration & dosage* / Q000276:immunology; D003673:Defective Viruses / Q000276:immunology / Q000502:physiology*; D016503:Drug Delivery Systems / Q000295:instrumentation* / Q000379:methods; D006801:Humans; D009092:Mucous Membrane / Q000276:immunology*; D014611:Vaccination / Q000295:instrumentation* / Q000379:methods
chemical_list: D000941:Antigens